Clinical Evidence / Publications / Engineering & simulation
A Percutaneous Catheter Solution as a Spacer for Regurgitant Heart Valve Disease
Min-Ku Chon et al.
Coatings · 2021
Summary
Describes a percutaneous, catheter-based spacer designed to reduce regurgitation in heart valve disease.
Part of the research behind the Pivot‑TR platform for tricuspid regurgitation.
Related publications
CCI 2026 · Clinical
Safety and Efficacy of Pivot-Bridge for Severe Functional Tricuspid Regurgitation: The First-in-Human Experiences
View detailsEuroIntervention 2026 · Clinical
A novel spacer for transcatheter treatment of tricuspid regurgitation
View detailsKCJ 2024 · Clinical